Ilan Goldberg
Overview
Explore the profile of Ilan Goldberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
790
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pardo K, Khasminsky V, Keret O, Benninger F, Goldberg I, Shelef I, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14551.
PMID: 39936326
Introduction: One of the pathological hallmarks of Alzheimer's disease (AD) is the accumulation of amyloid beta 42 (Aβ42). Decreased venous drainage may enhance Aβ42 accumulation. We aimed to compare venous...
2.
Shapiro J, Lyakhovitsky A, Freud T, Pavlotsky F, Khamaysi Z, Valdman-Grinshpoun Y, et al.
Acta Derm Venereol
. 2025 Jan;
105:adv41208.
PMID: 39749389
No abstract available.
3.
Imaging blood-brain barrier dysfunction in drug-resistant epilepsy: A multi-center feasibility study
Cafri N, Mirloo S, Zarhin D, Kamintsky L, Serlin Y, Alhadeed L, et al.
Epilepsia
. 2024 Nov;
66(1):195-206.
PMID: 39503526
Objective: Blood-brain barrier dysfunction (BBBD) has been linked to various neurological disorders, including epilepsy. This study aims to utilize dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to identify and compare brain...
4.
Fridberg G, Amit O, Karni C, Tshernichovsky D, Shasha D, Rouach V, et al.
Cancers (Basel)
. 2024 Oct;
16(20).
PMID: 39456614
-chronic graft vs. host disease (cGVHD) is associated with substantial morbidity and mortality. We aimed to analyze advances in treatment strategy and outcomes during the last decade due to the...
5.
Slutsky Bank E, Rozenblat M, Eytan O, Perelman M, Geller S, Sprecher E, et al.
Acta Dermatovenerol Croat
. 2023 Feb;
30(3):140-145.
PMID: 36812270
Mycosis Fungoides (MF) and Sézary syndrome (SS) are the most common forms of cutaneous T-cell lymphomas. Few validated prognostic factors have been reported in MF/SS, especially when compared with non-cutaneous...
6.
Geller S, Tel-Dan S, Solar I, Sprecher E, Goldberg I
Clin Lymphoma Myeloma Leuk
. 2022 Nov;
23(2):123-126.
PMID: 36424279
Background: The prognostic value of skin and blood T-cell receptor clonality in mycosis fungoides is a matter of debate. Our aim was to ascertain the relation between the presence of...
7.
Bar-Ilan E, Mashiah J, Alkalay R, Ingber A, Zahavi K, Bar J, et al.
Clin Exp Dermatol
. 2022 Mar;
47(9):1703-1706.
PMID: 35340038
Generalized acquired dermatoses can seldom manifest more prominently or exclusively along the lines of Blaschko. Six individuals with segmental atopic dermatitis (AD) have been reported to date. We present three...
8.
Oren-Shabtai M, Metzker A, Ben Amitai D, Sprecher E, Goldberg I
Acta Derm Venereol
. 2022 Mar;
102:adv00707.
PMID: 35312024
Segmental pigmentation disorder (SPD) is characterized by hypo- or hyper-pigmented patches segmentally distributed, present in infancy, more prominently in darker-skinned children. The aim of this study was to define the...
9.
Zelig D, Goldberg I, Shor O, Ben Dor S, Yaniv-Rosenfeld A, Milikovsky D, et al.
Epilepsia
. 2021 Nov;
63(1):190-198.
PMID: 34750812
Objective: Management of a patient presenting with a first seizure depends on the risk of additional seizures. In clinical practice, the recurrence risk is estimated by the treating physician using...
10.
Kaplan Y, Goldberg I, Sprecher E, Slodownik D
Fundam Clin Pharmacol
. 2021 Oct;
36(2):414-420.
PMID: 34668222
Delayed-onset T-cell-mediated cutaneous adverse drug reactions are an uncommon but potentially serious result of medication exposures. Identification of culprit medications is crucial, but clinical diagnosis is often difficult. Patch tests...